Meningococcal Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1065104
  • May 2021
  • Pharmaceuticals
  • 115 Pages
The global Meningococcal Vaccines market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Meningococcal Vaccines market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Meningococcal Vaccines market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Meningococcal Vaccines market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Pfizer Inc., Baxter, Novartis AG, Sanofi, JN-International Medical Corporation (Verdict Media Limited), BIO-MED, Serum Institute of India Pvt. Ltd., GlaxoSmithKline plc, Merck & Co., Inc., Hualan Biological Engineering Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Meningococcal Vaccines market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Meningococcal Vaccines market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Meningococcal Vaccines market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Meningococcal Vaccines market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Meningococcal Vaccines Market:
The Meningococcal Vaccines market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Pfizer Inc., Baxter, Novartis AG, Sanofi, JN-International Medical Corporation (Verdict Media Limited), BIO-MED, Serum Institute of India Pvt. Ltd., GlaxoSmithKline plc, Merck & Co., Inc., Hualan Biological Engineering Inc.

Meningococcal Vaccines Market Segment Analysis:
by Type
Quadrivalent Vaccines
Bivalent Vaccines
Serogroup A
Serogroup B
Serogroup X
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Geographic Coverage for Meningococcal Vaccines Market:
The market research report on global Meningococcal Vaccines market offers complete analysis across various regions across the world. The Meningococcal Vaccines market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Meningococcal Vaccines market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Meningococcal Vaccines Market Value and Forecast
  • US
  • Canada
Europe Meningococcal Vaccines Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Meningococcal Vaccines Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Meningococcal Vaccines Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Meningococcal Vaccines Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Meningococcal Vaccines market report:
  • The report provides key trends of the global Meningococcal Vaccines market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Meningococcal Vaccines industry
  • The report covers all the recent developments of the Meningococcal Vaccines market and helps to provide current industry updates
  • The report covers a detailed look over the global Meningococcal Vaccines Industry and provides with significant actionable insights
  • The Meningococcal Vaccines market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Meningococcal Vaccines market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Meningococcal Vaccines market
  • Comprehensive analysis of the Meningococcal Vaccines market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Meningococcal Vaccines market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Meningococcal Vaccines market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Meningococcal Vaccines market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Meningococcal Vaccines market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Meningococcal Vaccines market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Pfizer Inc.
  • Baxter
  • Novartis AG
  • Sanofi
  • JN-International Medical Corporation (Verdict Media Limited)
  • BIO-MED
  • Serum Institute of India Pvt. Ltd.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Hualan Biological Engineering Inc.
  • Quadrivalent Vaccines
  • Bivalent Vaccines
  • Serogroup A
  • Serogroup B
  • Serogroup X
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Meningococcal Vaccines Market Snapshot
          2.1.1. Global Meningococcal Vaccines Market By Type,2019
               2.1.1.1.Quadrivalent Vaccines
               2.1.1.2.Bivalent Vaccines
               2.1.1.3.Serogroup A
               2.1.1.4.Serogroup B
               2.1.1.5.Serogroup X
          2.1.2. Global Meningococcal Vaccines Market By Distribution Channel,2019
               2.1.2.1.Hospital Pharmacies
               2.1.2.2.Retail Pharmacies
               2.1.2.3.Online Pharmacies
          2.1.3. Global Meningococcal Vaccines Market By End-use,2019
          2.1.4. Global Meningococcal Vaccines Market By Geography,2019

3. Global Meningococcal Vaccines Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Meningococcal Vaccines Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Meningococcal Vaccines Market Size (US$), By Type, 2018 – 2028

5. Global Meningococcal Vaccines Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Meningococcal Vaccines Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Meningococcal Vaccines Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Meningococcal Vaccines Market Size (US$), By End-use, 2018 – 2028

7. Global Meningococcal Vaccines Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Meningococcal Vaccines Market Analysis, 2018 – 2028 
          7.2.1. North America Meningococcal Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Meningococcal Vaccines Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Meningococcal Vaccines Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Meningococcal Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Meningococcal Vaccines Market Analysis, 2018 – 2028 
          7.3.1.  Europe Meningococcal Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Meningococcal Vaccines Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Meningococcal Vaccines Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Meningococcal Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Meningococcal Vaccines Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Meningococcal Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Meningococcal Vaccines Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Meningococcal Vaccines Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Meningococcal Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Meningococcal Vaccines Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Meningococcal Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Meningococcal Vaccines Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Meningococcal Vaccines Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Meningococcal Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Meningococcal Vaccines Market Analysis, 2018 – 2028 
          7.6.1.  MEA Meningococcal Vaccines Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Meningococcal Vaccines Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Meningococcal Vaccines Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Meningococcal Vaccines Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Meningococcal Vaccines Providers
        8.4.1 Pfizer Inc.
                8.4.1.1 Business Description
                8.4.1.2 Pfizer Inc. Geographic Operations
                8.4.1.3 Pfizer Inc. Financial Information
                8.4.1.4 Pfizer Inc. Product Positions/Portfolio
                8.4.1.5 Pfizer Inc. Key Developments
        8.4.2 Baxter
                8.4.2.1 Business Description
                8.4.2.2 Baxter Geographic Operations
                8.4.2.3 Baxter Financial Information
                8.4.2.4 Baxter Product Positions/Portfolio
                8.4.2.5 Baxter Key Developments
        8.4.3 Novartis AG
                8.4.3.1 Business Description
                8.4.3.2 Novartis AG Geographic Operations
                8.4.3.3 Novartis AG Financial Information
                8.4.3.4 Novartis AG Product Positions/Portfolio
                8.4.3.5 Novartis AG Key Developments
        8.4.4 Sanofi
                8.4.4.1 Business Description
                8.4.4.2 Sanofi Geographic Operations
                8.4.4.3 Sanofi Financial Information
                8.4.4.4 Sanofi Product Positions/Portfolio
                8.4.4.5 Sanofi Key Developments
        8.4.5 JN-International Medical Corporation (Verdict Media Limited)
                8.4.5.1 Business Description
                8.4.5.2 JN-International Medical Corporation (Verdict Media Limited) Geographic Operations
                8.4.5.3 JN-International Medical Corporation (Verdict Media Limited) Financial Information
                8.4.5.4 JN-International Medical Corporation (Verdict Media Limited) Product Positions/Portfolio
                8.4.5.5 JN-International Medical Corporation (Verdict Media Limited) Key Developments
        8.4.6 BIO-MED
                8.4.6.1 Business Description
                8.4.6.2 BIO-MED Geographic Operations
                8.4.6.3 BIO-MED Financial Information
                8.4.6.4 BIO-MED Product Positions/Portfolio
                8.4.6.5 BIO-MED Key Developments
        8.4.7 Serum Institute of India Pvt. Ltd.
                8.4.7.1 Business Description
                8.4.7.2 Serum Institute of India Pvt. Ltd. Geographic Operations
                8.4.7.3 Serum Institute of India Pvt. Ltd. Financial Information
                8.4.7.4 Serum Institute of India Pvt. Ltd. Product Positions/Portfolio
                8.4.7.5 Serum Institute of India Pvt. Ltd. Key Developments
        8.4.8 GlaxoSmithKline plc
                8.4.8.1 Business Description
                8.4.8.2 GlaxoSmithKline plc Geographic Operations
                8.4.8.3 GlaxoSmithKline plc Financial Information
                8.4.8.4 GlaxoSmithKline plc Product Positions/Portfolio
                8.4.8.5 GlaxoSmithKline plc Key Developments
        8.4.9 Merck & Co., Inc.
                8.4.9.1 Business Description
                8.4.9.2 Merck & Co., Inc. Geographic Operations
                8.4.9.3 Merck & Co., Inc. Financial Information
                8.4.9.4 Merck & Co., Inc. Product Positions/Portfolio
                8.4.9.5 Merck & Co., Inc. Key Developments
        8.4.10 Hualan Biological Engineering Inc.
                8.4.10.1 Business Description
                8.4.10.2 Hualan Biological Engineering Inc. Geographic Operations
                8.4.10.3 Hualan Biological Engineering Inc. Financial Information
                8.4.10.4 Hualan Biological Engineering Inc. Product Positions/Portfolio
                8.4.10.5 Hualan Biological Engineering Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Meningococcal Vaccines Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Meningococcal Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Meningococcal Vaccines Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Meningococcal Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Meningococcal Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Meningococcal Vaccines Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Meningococcal Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Meningococcal Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Meningococcal Vaccines Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Meningococcal Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Meningococcal Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Meningococcal Vaccines Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Meningococcal Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Meningococcal Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Meningococcal Vaccines Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Meningococcal Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Meningococcal Vaccines: Market Segmentation 
FIG. 2 Global Meningococcal Vaccines Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Meningococcal Vaccines Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Meningococcal Vaccines Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Meningococcal Vaccines Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Meningococcal Vaccines Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Meningococcal Vaccines Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Meningococcal Vaccines Providers, 2019
FIG. 11 Global Meningococcal Vaccines Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Meningococcal Vaccines Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Meningococcal Vaccines Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Meningococcal Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Meningococcal Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Meningococcal Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Meningococcal Vaccines Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Meningococcal Vaccines Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Meningococcal Vaccines market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Meningococcal Vaccines Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Meningococcal Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  North America Meningococcal Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  North America Meningococcal Vaccines Market Value, By Country, 2018 – 2028
TABLE  Europe Meningococcal Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Europe Meningococcal Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Europe Meningococcal Vaccines Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Meningococcal Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Meningococcal Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Meningococcal Vaccines Market Value, By Country, 2018 – 2028
TABLE  Latin America Meningococcal Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Meningococcal Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Meningococcal Vaccines Market Value, By Country, 2018 – 2028
TABLE  MEA Meningococcal Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  MEA Meningococcal Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  MEA Meningococcal Vaccines Market Value, By Country, 2018 – 2028
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Baxter: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  JN-International Medical Corporation (Verdict Media Limited): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BIO-MED: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Serum Institute of India Pvt. Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hualan Biological Engineering Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Meningococcal Vaccines Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Meningococcal Vaccines Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Meningococcal Vaccines Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Meningococcal Vaccines Market, By Geography, 2019 (US$ Mn)
FIG.  Global Meningococcal Vaccines Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Meningococcal Vaccines Providers, 2016
FIG.  Global Meningococcal Vaccines Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Bivalent Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Serogroup A Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Serogroup B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Serogroup X Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Meningococcal Vaccines Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Online Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Meningococcal Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Meningococcal Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Meningococcal Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Meningococcal Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Meningococcal Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Meningococcal Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Meningococcal Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Meningococcal Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Meningococcal Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Meningococcal Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Meningococcal Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Meningococcal Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Meningococcal Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Meningococcal Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Meningococcal Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Meningococcal Vaccines Market Value, 2018 – 2028, (US$ Mn)